TP53 and cancer: In the case of Ru(II) curcumin, it has been reported that its effect (in various cancer models) is associated with activation of wild-type p53 and Nuclear Factor Erythroid 2–Related Factor 2 (NRF2) signaling, as well as a reduction in the protein level of mutated oncogenic p53.